Slides on Shingles in the COVID-19 Era: Shingles Vaccination Guidelines

Listen to expert insights from Martin C. Mahoney, MD, PhD, on new data for vaccine-preventable diseases presented at the IDWeek meeting, including pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza.

Martin C. Mahoney, MD, PhD Released: December 6, 2021

Download key slides on guidance and recommendations on shingles vaccination rates and increasing vaccine uptake in the COVID-19 era.

Dalilah Restrepo, MD Released: December 3, 2021

Guidance on overcoming vaccination barriers and strategies to increase shingles vaccine uptake, from Dalilah Restrepo, MD, and Clinical Care Options (CCO)

Dalilah Restrepo, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: December 3, 2021 Expired: December 2, 2022

Expert IDWeek 2021 video: vaccines for pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza, from CCO

Martin C. Mahoney, MD, PhD Released: November 11, 2021